Clinical Trials Logo

Clinical Trial Summary

Evaluation of safety and clinical efficacy of an active ingredient versus placebo for the treatment of mild to moderate Atopic Dermatitis (AD) adults.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05057351
Study type Interventional
Source Greenpharma S.A.S.
Status Completed
Phase N/A
Start date September 1, 2020
Completion date March 31, 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03250663 - Eucrisa for Atopic Dermatitis Phase 1
Terminated NCT00996008 - CT 327 in the Treatment of Atopic Dermatitis Phase 2
Completed NCT01568489 - Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis Phase 2
Completed NCT01079897 - Efficacy and Safety of an Ectoine-containing Cream in the Treatment of Mild to Moderate Atopic Dermatitis N/A
Completed NCT02079688 - Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema Phase 2
Completed NCT00568412 - A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis Phase 4